Patient satisfaction and tolerance of virtual reality rehabilitation in subacute ischemic stroke: a pilot study

If you're not measuring satisfaction against 100% recovery you're using the tyranny of low expectations to disguise the fact YOU'RE A COMPLETTE FUCKING FAILURE AT STROKE RECOVERY!

 Patient satisfaction and tolerance of virtual reality rehabilitation in subacute ischemic stroke: a pilot study

Sarka Banikova^1,2,3Alice Najsrova²István Szegedi^2,4,5Kateřina Vitová¹Iva Fiedorová^1,3Jana Trdá⁶Ondrej Volny^2,4*

• ¹Department of Rehabilitation and Sports Medicine, University Hospital Ostrava, Ostrava, Czechia
• ²Centre for Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czechia
• ³Department of Rehabilitation and Sports Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czechia
• ⁴Department of Neurology, University Hospital Ostrava, Ostrava, Czechia
• ⁵Department of Neurology, University of Debrecen, Debrecen, Debrecen, Hungary
• ⁶VR LIFE Ltd., Ostrava, Czechia

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

Email

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Background: Virtual reality (VR) rehabilitation represents a promising technological approach in post-stroke neurorehabilitation, offering immersive, engaging therapy environments. However, limited data exist on patient satisfaction and tolerance in clinical practice, particularly during the subacute phase of stroke recovery. Objective: To evaluate patient satisfaction and tolerance of VR rehabilitation in patients with subacute ischemic stroke and assess physiotherapist perceptions of treatment outcomes compared to conventional rehabilitation. Methods: A prospective pilot study was conducted from January 1-December 31, 2024, at University Hospital Ostrava, Czech Republic. Patients in the subacute phase of ischemic stroke (≤2 weeks post-stroke) underwent VR rehabilitation using the MDR-certified VR Vitalis® Pro system. Patient satisfaction was measured using the User Satisfaction Evaluation Questionnaire (USEQ). Physiotherapists assessed treatment outcomes on a 5-point scale compared to conventional rehabilitation. Vital signs were monitored pre- and post-intervention. Results: Nineteen patients (mean age 67.7 ± 11.2 years, 52.6% female) completed VR rehabilitation. The mean USEQ satisfaction score was 25.0 ± 6.8 points (range 7-30). High satisfaction (≥25 points) was achieved in 68.4% of patients, with only 5.3% reporting low satisfaction. Individual question analysis revealed highest ratings for information clarity (4.63 ± 0.96) and perceived rehabilitation benefit (4.37 ± 1.12), with 63.2% reporting no discomfort. Physiotherapists rated 31.6% of patients as showing better outcomes than expected with conventional therapy, while 52.6% showed similar outcomes. No serious adverse events were recorded. Conclusions: VR rehabilitation demonstrated high patient satisfaction and excellent tolerance in subacute stroke patients. Individual USEQ analysis revealed strong acceptance for system clarity and rehabilitation benefit. These findings support VR rehabilitation feasibility in clinical stroke care.

Keywords: virtual reality, stroke rehabilitation, Patient Satisfaction, Neurorehabilitation, subacute stroke

Received: 06 Jul 2025; Accepted: 31 Jul 2025.

Copyright: © 2025 Banikova, Najsrova, Szegedi, Vitová, Fiedorová, Trdá and Volny. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ondrej Volny, Centre for Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czechia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.